Prenatal nicotine exposure: Effects on locomotor activity and central [125I]α-BT binding in rats

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 3, 2000, Pages 495-500

  Tizabi, Yousef ^a   Russell, Lemuel T ^a   Nespor, Stephanie M ^b   Perry, David C ^c   Grunberg, Neil E ^b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Autoradiography; Hippocampus; Locomotor activity; Nicotine; Nicotinic receptors; Prenatal; Rat

Indexed keywords

ALPHA BUNGAROTOXIN I 125; NICOTINE; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; BRAIN REGION; COGNITION; CONTROLLED STUDY; FEMALE; FETUS; HIPPOCAMPUS; HYPERACTIVITY; LOCOMOTION; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

ANIMALS; BINDING SITES; BUNGAROTOXINS; FEMALE; GANGLIONIC STIMULANTS; HIPPOCAMPUS; IODINE RADIOISOTOPES; MOTOR ACTIVITY; NICOTINE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 0033922973     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00171-4     Document Type: Article

References (57)

1. Acri J.B., Brown K.J., Saah M.I., Grunberg N.E. Strain and age differences in acoustic startle responses and effects of nicotine in rats. Pharmacol. Biochem. Behav. 50:1995;191-198.
2. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schiz. Bull. 24:1998;189-202.
3. Agulhon C., Charnay Y., Vallet P., Bertrand D., Malafosse A. Distribution of mRNA for the α4 subunit of the nicotinic acetylcholine receptor in the human fetal brain. Mol. Brain Res. 58:1998;123-131.
4. Barrantes G.E., Rogers A.T., Lindstrom J., Wonnacott S. α-Bungarotoxin binding sites in rat hippocampal and cortical cultures. Initial characterisation, colocalisation with α-7 subunits and up-regulation by nicotine treatment Brain Res. 672:1995;228-236.
5. Butler N.R., Goldstein H. Smoking in pregnancy and subsequent child development. Br. Med. J. 4:1973;573-574.
6. 3H] (-) nicotine binding sites in fetal human brain. Brain Res. 475:1988;1-7.
7. 125I-alpha-bungarotoxin J. Neurosci. 5:1985;1307-1315.
8. Clegg D.A., O'Hara B.F., Heller H.C., Kilduff T.S. Nicotine administration differentially affects gene expression in the maternal and fetal circadian clock. Dev. Brain Res. 84:1995;46-54.
9. Decker M.W., Brioni J.D., Bannon A.W., Arneric S.P. Diversity of neuronal nicotinic acetylcholine receptors. Lessons from behavior and implications for CNS therapeutics Life Sci. 56:1995;545-570.
10. Denson R., Anson J.L., McWatters M.A. Hyperkinesis and maternal smoking. Can. Psychiatr. Assoc. J. 20:1975;183-187.
11. Fergusson D.M., Horwood L.J., Lynskey M.T. Maternal smoking before and after pregnancy. Effects on behavioral outcomes in middle childhood Pediatrics. 92:1993;815-822.
12. Fergusson D.M., Woodward L.J., Horwood L.J. Maternal smoking during pregnancy and psychiatric adjustment in late adolescence. Arch. Gen. Psychiatry. 55:1998;721-727.
13. Fung Y.K. Postnatal behavioral effects of maternal nicotine exposure in rats. J. Pharm. Pharmacol. 40:1988;870-872.
14. Fung Y.K., Lau Y.S. Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems. Pharmacol. Biochem. Behav. 33:1989;1-6.
15. 3H]nicotine binding in the fetal brain. Int. J. Dev. Neurosci. 3:1985;567-571.
16. Hellstrom-Lindahl E., Gorbounova O, Seiger A., Mousavi M., Nordberg A. Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord. Dev. Brain Res. 108:1998;147-160.
17. Hibberd A.R., O'Connor V., Gorrod J.W. Detection of nicotine, nicotine-1′-N-oxide and cotinine in maternal and fetal body fluids. Gorrod J.E. Biological oxidation of nitrogen. 1978;353-361 Elsevier, Amsterdam.
18. Kristjansson E.A., Fried P.A., Watkinson B. Maternal smoking affects children's vigilance performance. Drug Alcohol Depend. 24:1989;11-19.
19. Levin E.D., Wilkerson A., Jones J.P., Christopher N.C., Briggs S.J. Prenatal nicotine effects on memory in rats. Pharmacological and behavioural challenges Dev. Brain Res. 97:1996;207-215.
20. Lichtensteiger W., Ribary U., Schlumpf M., Odermatt B., Widmer R. Prenatal adverse effects of nicotine on the developing brain. Prog. Brain Res. 73:1988;137-157.
21. Lindstrom J. Nicotinic acetylcholine receptors in health and disease. Mol. Neurobiol. 15:1997;193-222.
22. Luck W., Nau H. Exposure of the fetus, neonate, and nursed infant to nicotine and cotinine from maternal smoking (letter). N. Engl. J. Med. 311:1984;672.
23. Luck W., Nau H., Hansen R., Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev. Pharmacol. Ther. 8:1985;384-395.
24. Martin J.C., Martin D.C., Radow B., Sigman G. Growth, development and activity in rat offspring following maternal drug exposure. Exp. Aging Res. 2:1976;235-251.
25. McIntosh D.E., Mulkins R.S., Dean R.S. Utilization of maternal perinatal risk indicators in the differential diagnosis of ADHD and UADD children. Int. J. Neurosci. 81:1995;35-46.
26. Miao H., Liu C., Bishop K., Gong Z.H., Nordberg A., Zhang X. Nicotine exposure during a critical period of development leads to persistent changes in nicotinic acetylcholine receptors of adult rat brain. J. Neurochem. 70:1998;752-762.
27. Milberger S., Biederman J., Faraone S.V., Chen L., Jones B.A. Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children? Am. J. Psychiatry. 153:1996;1138-1142.
28. Milerad J., Sundell H. Nicotine exposure and the risk of SIDS. Pediatrics. 389:1993;70-72.
29. 3H nicotine binding sites in rat brain regions. an autoradiographic study Dev. Brain Res. 68:1992;163-174.
30. Naeye R.L., Peters E.C. Mental development of children whose mothers smoked during pregnancy. Obst. Gynecol. 64:1984;601-607.
31. Navarro H.A., Seidler F.J., Eylers J.P., Baker F.E., Dobbins S.S., Lappi S.E., Slotkin T.A. Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J. Pharmacol. Exp. Ther. 251:1989;894-900.
32. Peng X., Gerzanich V., Anand R., Whitiing P.J., Lindstrom J. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol. 46:1994;523-530.
33. 3H]Epibatidine labels nicotinic receptors in rat brain. An autoradiographic study J. Pharmacol. Exp. Ther. 275:1995;1030-1034.
34. Popke E.J., Tizabi Y., Rahman M.A., Nespor S.M., Grunberg N.E. Prenatal nicotine exposure. Effects on pre-pulse inhibition and central nicotinic receptors Pharmacol. Biochem. Behav. 58:1997;843-849.
35. Pugh P., Berg D. Neuronal acetylcholine receptors that bind α-bungarotoxin mediate neurite retraction in a calcium-dependent manner. J. Neurosci. 14:1994;889-896.
36. Quick M. Growth related role for the nicotinic α-bungarotoxin receptor. Clarke P.B.S., Quick M., Adlkofer F., Thurau K. Effects of nicotine on biological systems II. 1995;145-150 Kirkhauser, Basel.
37. Richardson S.A., Tizabi Y. Hyperactivity in the offspring of nicotine-treated rats. Role of the mesolimbic and nigrostriatal dopaminergic pathways Pharmacol. Biochem. Behav. 47:1994;331-337.
38. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
39. Roy T.S., Andrews J.E., Seidler F.J., Slotkin T.A. Nicotine evokes cell death in embryonic rat brain during neurulation. J. Pharmacol. Exp. Ther. 287:1998;1136-1144.
40. Sastry B.V.R., Chance M.B., Hemontolor M.E., Goddijn-Wessel T.A.W. Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon. Pharmacology. 57:1998;104-116.
41. Schlumpf M., Gahwiler M., Ribrary U., Lichtensteinger W.A. New device for monitoring early motor development. Prenatal nicotine-induced changes Pharmacol. Biochem. Behav. 30:1988;199-203.
42. Sershen H., Reith M.E.A., Banay-Schwartz M., Lajtha A. Effects of prenatal administration of nicotine on amino acid pools, protein metabolism, and nicotine binding in the brain. Neurochem. Res. 7:1982;1515-1522.
43. Shacka J.J., Robinson S.E. Postnatal development regulation of neuronal nicotinic receptor subunit α7 and multiple α4 and β2 mRNA species in the rat. Dev. Brain Res. 109:1998;67-75.
44. Slotkin T.A. Fetal nicotine or cocaine exposure. Which one is worse? J. Pharmacol. Exp. Ther. 285:1998;931-945.
45. 3H]nicotine binding sites in brain regions of rats exposed to nicotine prenatally via maternal injections or infusions. J. Pharmacol. Exp. Ther. 242:1987;232-237.
46. Sorenson C.A., Raskin L.A., Suh Y. The effects of prenatal nicotine on radial-arm maze performance in rats. Pharmacol. Biochem. Behav. 40:1991;991-993.
47. 125I-alpha-bungarotoxin to nicotinic sites in the chicken. J. Comp. Neurol. 323:1992;1-12.
48. Stevens K.E., Wear K.D. Normalizing effects of nicotine and a novel nicotinic agonist on hippocampal auditory gating in two animal models. Pharmacol. Biochem. Behav. 57:1997;869-874.
49. Streissguth A.P., Martin D.C., Barr H.M., Sandman B.M., Kirchner G.L., Darby B.L. Intrauterine alcohol and nicotine exposure. Attention and reaction time in 4-year-old children Dev. Psychol. 20:1984;533-541.
50. Swerdlow N.R., Braff D.L., Geyer M.A., Koob G.F. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol. Psychiatry. 21:1986;23-33.
51. Tizabi Y., Popke E.J., Rahman M.A., Nespor S.M., Grunberg N.E. Hyperactivity induced by prenatal nicotine exposure is associated with an increase in cortical nicotinic receptors. Pharmacol. Biochem. Behav. 58:1997;141-146.
52. Van De Kamp J.L., Collins A.C. Prenatal nicotine alters nicotinic receptor development in the mouse brain. Pharmacol. Biochem. Behav. 47:1994;889-900.
53. Wang F., Nelson M.E., Kuryatov A., Olale F., Cooper J., Deyser K., Lindstrom J. Chronic nicotine treatment up-regulates human α3β2 but not α3β4 acetylcholine receptors stably transfected in human embryonic kidney cells. J. Biol. Chem. 273:1998;28721-28732.
54. Winders S.E., Grunberg N.E., Benowitz N.L., Alvares A.P. Effects of stress on circulating nicotine and cotinine levels and in vitro nicotine metabolism in the rat. Psychopharmacology (Berlin). 137:1998;383-390.
55. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
56. Wonnacott S. The paradox of nicotinic acetylcholine receptor up-regulation by nicotine. Trends Pharmacol. Sci. 11:1990;216-219.
57. Zhang X., Chuan L., Maio H., Gong Z., Nordberg A. Postnatal changes of nicotinic acetylcholine receptor α2, α3, α4, α7 and β2 subunits genes expression in rat brain. Int. J. Dev. Neurosci. 16:1998;507-518.